Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis

Dorsa Sohaei, Simon Thebault, Lisa M. Avery, Ihor Batruch, Brian Lam, Wei Xu, Rubah S. Saadeh, Isobel A. Scarisbrick, Eleftherios P. Diamandis, Ioannis Prassas, Mark S. Freedman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds